Epigral approves re-appointment of three directors
Epigral Limited announced the re-appointment of three Non-Executive Independent Directors for a second term of five years effective May 20, 2026. Shareholders approved the resolutions via remote e-voting with a requisite majority.

*this image is generated using AI for illustrative purposes only.
Epigral Limited has announced the outcome of its postal ballot process regarding the re-appointment of three Non-Executive Independent Directors. The company sought shareholder approval for the re-appointment of Mr. Sanjay Asher, Mr. Kanubhai Patel, and Mr. Raju Swamy for a second term of five years effective from May 20, 2026. The resolutions were passed through a remote e-voting process conducted between April 20, 2026, and May 19, 2026.
Voting Results Summary
The special resolutions were approved by the members with the requisite majority. The scrutinizer's report confirmed that the resolutions were passed on May 19, 2026, the last date of voting. The total number of shareholders eligible to vote as on the record date of April 10, 2026, was 79,534.
Detailed Voting Breakdown
The table below summarizes the voting results for the three resolutions:
| Resolution | Votes For | Votes Against | % For | % Against |
|---|---|---|---|---|
| Re-appointment of Mr. Sanjay Asher | 27,392,458 | 1,335,541 | 95.35 | 4.65 |
| Re-appointment of Mr. Kanubhai Patel | 28,721,547 | 6,552 | 99.98 | 0.02 |
| Re-appointment of Mr. Raju Swamy | 27,604,888 | 1,123,211 | 96.09 | 3.91 |
Key Voting Details
For the resolution regarding Mr. Sanjay Asher, 219 members voted in favour, while 50 members voted against. The resolution for Mr. Kanubhai Patel saw 243 members in favour and 27 against. The re-appointment of Mr. Raju Swamy was supported by 240 members and opposed by 30 members. There were no invalid votes recorded for any of the resolutions.
The postal ballot notice was dispatched to shareholders on April 17, 2026. The scrutinizer, M/s. Utkarsh Shah & Co., verified the voting process and confirmed the results. The detailed voting results and the scrutinizer's report are available on the company's website.
How might the re-appointment of these three independent directors influence Epigral Limited's upcoming strategic decisions, particularly in areas like capital allocation or expansion plans?
Given that Mr. Sanjay Asher and Mr. Raju Swamy faced relatively higher opposition votes (~4-5%), could this signal growing shareholder activism at Epigral, and how might management respond to address minority concerns?
What key governance initiatives or board committee changes can be expected under the continued leadership of these independent directors during their second five-year term starting May 2026?

































